Transcriptomic Platform CRO2 INSERM, Faculty of Medicine, University of the Mediterranean (Aix-Marseille II), Marseille, France.
J Mol Diagn. 2012 Jul;14(4):314-21. doi: 10.1016/j.jmoldx.2012.02.008. Epub 2012 May 27.
MicroRNAs (miRNAs) are small noncoding RNAs of approximately 18 to 25 nucleotides in length that negatively regulate gene expression via either the degradation or translational inhibition of their target mRNAs. Because miRNAs are essential for the regulation of critical physiological processes as well as a variety of pathological events, they have emerged as a novel class of molecular diagnostic biomarkers and therapeutic agents or targets. Accordingly, the need for novel methods for the quantification of miRNA has increased due to interest in their clinical implications. Currently, real-time quantitative polymerase chain reaction (qPCR) is considered the most robust technology for nucleic acid quantification. Different tools for miRNA quantification by using qPCR are now commercially available, but only relative quantification strategies have been reported. This situation may be partly due to the difficulty in obtaining an appropriate molecule with which to establish an miRNA calibration range. Here, we describe a rapid and convenient strategy for the development of a calibrator, which enables the absolute quantification of miRNAs by using qPCR and allows the cloning of a synthetic sequence of interest instead of a PCR product into a plasmid.
微小 RNA(miRNA)是大约 18 到 25 个核苷酸长度的小非编码 RNA,通过靶 mRNA 的降解或翻译抑制来负调控基因表达。由于 miRNA 对于调节关键生理过程以及各种病理事件至关重要,因此它们已成为一类新型的分子诊断生物标志物和治疗剂或靶标。因此,由于对其临床意义的关注,对 miRNA 定量的新方法的需求有所增加。目前,实时定量聚合酶链反应(qPCR)被认为是核酸定量最可靠的技术。现在有许多用于 qPCR 进行 miRNA 定量的商业工具,但仅报道了相对定量策略。这种情况可能部分归因于难以获得合适的分子来建立 miRNA 校准范围。在这里,我们描述了一种快速便捷的校准器开发策略,该策略允许通过 qPCR 对 miRNA 进行绝对定量,并允许将感兴趣的合成序列而不是 PCR 产物克隆到质粒中。